000 03919nlm1a2200589 4500
001 664517
005 20231030041932.0
035 _a(RuTPU)RU\TPU\network\35701
035 _aRU\TPU\network\28422
090 _a664517
100 _a20210416a2018 k y0engy50 ba
101 0 _aeng
102 _aCH
135 _adrcn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aExposure to Silver Nanospheres Leads to Altered Respiratory Mechanics and Delayed Immune Response in an in Vivo Murine Model
_fDanielle Botelho, B. F. Leo, Christopher Massa [et al.]
203 _aText
_celectronic
300 _aTitle screen
320 _a[References: 21 tit.]
330 _aHere we examine the organ level toxicology of both carbon black (CB) and silver nanoparticles (AgNP). We aim to determine metal-specific effects to respiratory function, inflammation and potential interactions with lung lining fluid (LLF). C57Bl6/J male mice were intratracheally instilled with saline (control), low (0.05 [mu]g/g) or high (0.5 [mu]g/g) doses of either AgNP or CB 15 nm nanospheres. Lung histology, cytology, surfactant composition and function, inflammatory gene expression, and pulmonary function were measured at 1, 3, and 7 days post-exposure. Acutely, high dose CB resulted in an inflammatory response, increased neutrophilia and cytokine production, without alteration in surfactant composition or respiratory mechanics. Low dose CB had no effect. Neither low nor high dose AgNPs resulted in an acute inflammatory response, but there was an increase in work of breathing. Three days post-exposure with CB, a persistent neutrophilia was noted. High dose AgNP resulted in an elevated number of macrophages and invasion of lymphocytes. Additionally, AgNP treated mice displayed increased expression of IL1B, IL6, CCL2, and IL10. However, there were no significant changes in respiratory mechanics. At day 7, inflammation had resolved in AgNP-treated mice, but tissue stiffness and resistance were significantly decreased, which was accompanied by an increase in surfactant protein D (SP-D) content. These data demonstrate that the presence of metal alters the response of the lung to nanoparticle exposure. AgNP-surfactant interactions may alter respiratory function and result in a delayed immune response, potentially due to modified airway epithelial cell function.
461 _tFrontiers in Pharmacology
463 _tVol. 9
_v[213, 9 p.]
_d2018
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
610 1 _asilver nanoparticles
610 1 _alung
610 1 _apulmonary function
610 1 _asurfactant
610 1 _ainflammation
610 1 _aнаночастицы
610 1 _aлегкие
610 1 _aсеребро
610 1 _aвоспаление
610 1 _aиммунные процессы
701 1 _aBotelho
_bDanielle
_gD.
701 1 _aLeo
_bB. F.
_gBey Fen
701 1 _aMassa
_bChristopher
_gCh. B.
701 1 _aSarkar
_bS.
_gSrijata
701 1 _aTetley
_bT. D.
_gTeresa
701 1 _aChung
_bK. F.
_gKian Fan
701 1 _aChen
_bS.
_gShu
701 1 _aRyan
_bM. P.
_gMary
701 1 _aPorter
_bA. E.
_gAlexandra
701 1 _aAtochina
_bE. N.
_cbiophysicist
_cDirector of RASA Center in Tomsk of Tomsk Polytechnic University
_f1963-
_gElena Nikolaevna
_2stltpush
_3(RuTPU)RU\TPU\pers\37356
701 1 _aZhang
_bJu.
_gJunfeng
701 1 _aSchwander
_bS. K.
_gStephan
701 1 _aGow
_bA. J.
_gAndrew John
712 0 2 _aНациональный исследовательский Томский политехнический университет
_bИнженерная школа природных ресурсов
_bОтделение химической инженерии
_h8085
_2stltpush
_3(RuTPU)RU\TPU\col\23513
801 2 _aRU
_b63413507
_c20210416
_gRCR
856 4 _uhttps://doi.org/10.3389/fphar.2018.00213
942 _cCF